Skip to main content
Erschienen in: Diabetologia 11/2009

01.11.2009 | Article

Beta cell (dys)function in non-diabetic offspring of diabetic patients

verfasst von: M. Stadler, G. Pacini, J. Petrie, A. Luger, C. Anderwald, on behalf of the RISC Investigators

Erschienen in: Diabetologia | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The first-degree offspring of patients with type 2 diabetes are prone to develop type 2 diabetes, and have both insulin resistance and beta cell impairment. However, it is still unclear whether both pathophysiological features are inseparably combined and which is the outstanding determinant in the offspring.

Methods

Glucose metabolism, insulin sensitivity (calculated as M value divided by insulin [M/I]) and beta cell function were studied in the offspring of individuals with type 2 diabetes (n = 187; 57% females; age 43.8 ± 8.1 years; BMI 26.8 ± 4.5 kg/m2) and in individuals without a family history of type 2 diabetes (controls, n = 519, 55% females; age 43.4 ± 8.2 years; BMI 26.4 ± 3.7 kg/m2, no significant differences between the groups for any characteristic) by performance of 75 g OGTT and 2 h hyperinsulinaemic (40 mU min−1 m−2)–isoglycaemic clamp tests. Beta cell function was evaluated by calculating insulinogenic index (IGI) from C-peptide AUC:glucose AUC ratios from the first hour of OGTT (IGI[60 min]) and from the total OGTT (IGI[120 min]).

Results

During the OGTT, the offspring of individuals with type 2 diabetes showed 4–14% higher plasma glucose from 30 to 120 min (p < 0.05) and 20–29% higher serum insulin from 90 to 120 min, but decreased IGI(60 min) and IGI(120 min) (p < 0.05). M/I was 11% lower in the offspring of affected individuals than in controls (p < 0.01). To study the offspring of patients with type 2 diabetes with insulin sensitivity similar to that of the control group, the offspring of affected patients were divided into M/I quartiles. Those in the third M/I quartile showed M/I values and major anthropometric characteristics similar to those of the controls, but insulin AUC and C-peptide AUC values were lower in the first hour and the total OGTT (p < 0.05). The third M/I quartile had lower IGI values at 60 min and 120 min: 11% and 14% lower, respectively (p < 0.02).

Conclusions/interpretation

The first-degree offspring of type 2 diabetic patients show insulin resistance and beta cell dysfunction in response to oral glucose challenge. Beta cell impairment exists in insulin-sensitive offspring of patients with type 2 diabetes, suggesting beta cell dysfunction to be a major defect determining diabetes development in diabetic offspring.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929CrossRefPubMed Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929CrossRefPubMed
2.
Zurück zum Zitat Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909–915PubMed Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909–915PubMed
3.
Zurück zum Zitat Turner RC, Mathews DR, Holman RR, Peto J (1982) Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet 1:596–598CrossRefPubMed Turner RC, Mathews DR, Holman RR, Peto J (1982) Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet 1:596–598CrossRefPubMed
4.
Zurück zum Zitat Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed
5.
Zurück zum Zitat Ferrannini E, Balkau B, Coppack SW et al (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92:2885–2892CrossRefPubMed Ferrannini E, Balkau B, Coppack SW et al (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92:2885–2892CrossRefPubMed
6.
Zurück zum Zitat Ferrannini E (1998) Insulin resistance vs insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477–490CrossRefPubMed Ferrannini E (1998) Insulin resistance vs insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477–490CrossRefPubMed
7.
Zurück zum Zitat Anderwald C, Bernroider E, Krssak M et al (2002) Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51:3025–3032CrossRefPubMed Anderwald C, Bernroider E, Krssak M et al (2002) Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51:3025–3032CrossRefPubMed
8.
Zurück zum Zitat Perseghin G, Ghosh S, Gerow K, Shulman GI (1997) Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001–1009CrossRefPubMed Perseghin G, Ghosh S, Gerow K, Shulman GI (1997) Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001–1009CrossRefPubMed
9.
Zurück zum Zitat Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMed Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMed
10.
Zurück zum Zitat Ahren B, Pacini G (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104CrossRefPubMed Ahren B, Pacini G (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104CrossRefPubMed
11.
Zurück zum Zitat Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed
12.
Zurück zum Zitat Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570CrossRefPubMed Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570CrossRefPubMed
13.
Zurück zum Zitat Kozakova M, Palombo C, Paterni M et al (2008) Body composition and common carotid artery remodeling in a healthy population. J Clin Endocrinol Metab 93:3325–3332CrossRefPubMed Kozakova M, Palombo C, Paterni M et al (2008) Body composition and common carotid artery remodeling in a healthy population. J Clin Endocrinol Metab 93:3325–3332CrossRefPubMed
14.
Zurück zum Zitat Anderwald C, Anderwald-Stadler M, Promintzer M et al (2007) The Clamp-Like Index: a novel, highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance test in nondiabetic humans. Diabetes Care 30:2374–2380CrossRefPubMed Anderwald C, Anderwald-Stadler M, Promintzer M et al (2007) The Clamp-Like Index: a novel, highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance test in nondiabetic humans. Diabetes Care 30:2374–2380CrossRefPubMed
15.
Zurück zum Zitat Stadler M, Anderwald C, Karer T et al (2006) Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: a sign of impaired beta-cell function? Diabetes Care 29:1031–1038CrossRefPubMed Stadler M, Anderwald C, Karer T et al (2006) Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: a sign of impaired beta-cell function? Diabetes Care 29:1031–1038CrossRefPubMed
16.
Zurück zum Zitat Anderwald-Stadler M, Krebs M, Promintzer M et al (2007) Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293:E1393–E1398CrossRefPubMed Anderwald-Stadler M, Krebs M, Promintzer M et al (2007) Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293:E1393–E1398CrossRefPubMed
17.
Zurück zum Zitat Promintzer M, Krebs M, Todoric J et al (2007) Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab Nov 92:4306–4312CrossRef Promintzer M, Krebs M, Todoric J et al (2007) Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab Nov 92:4306–4312CrossRef
18.
Zurück zum Zitat Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72:298–301CrossRefPubMed Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72:298–301CrossRefPubMed
19.
Zurück zum Zitat Stadler M, Auinger M, Anderwald C et al (2006) Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. J Clin Endocrinol Metab 91:3814–3820CrossRefPubMed Stadler M, Auinger M, Anderwald C et al (2006) Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. J Clin Endocrinol Metab 91:3814–3820CrossRefPubMed
20.
Zurück zum Zitat Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M (1998) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101:86–96CrossRefPubMed Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M (1998) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101:86–96CrossRefPubMed
21.
Zurück zum Zitat Jacob S, Machann J, Rett K et al (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113–1119CrossRefPubMed Jacob S, Machann J, Rett K et al (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113–1119CrossRefPubMed
22.
Zurück zum Zitat Perseghin G, Scifo P, de Cobelli F et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606CrossRefPubMed Perseghin G, Scifo P, de Cobelli F et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606CrossRefPubMed
23.
Zurück zum Zitat Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671CrossRefPubMed Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671CrossRefPubMed
24.
Zurück zum Zitat Psyrogiannis A, Habeos I, Kyriazopoulou V (2003) Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents. Lipids Health Dis 2:8CrossRefPubMed Psyrogiannis A, Habeos I, Kyriazopoulou V (2003) Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents. Lipids Health Dis 2:8CrossRefPubMed
25.
Zurück zum Zitat Anderwald C, Pfeiler G, Nowotny P et al (2008) Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. Eur J Clin Invest 38:227–237CrossRefPubMed Anderwald C, Pfeiler G, Nowotny P et al (2008) Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. Eur J Clin Invest 38:227–237CrossRefPubMed
26.
Zurück zum Zitat Nyholm B, Walker M, Gravholt CH et al (1999) Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia 42:1314–1324CrossRefPubMed Nyholm B, Walker M, Gravholt CH et al (1999) Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia 42:1314–1324CrossRefPubMed
27.
Zurück zum Zitat Bacha F, Gungor N, Arslanian SA (2008) Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr 152:618–621CrossRefPubMed Bacha F, Gungor N, Arslanian SA (2008) Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr 152:618–621CrossRefPubMed
28.
Zurück zum Zitat Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17:305–322CrossRefPubMed Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17:305–322CrossRefPubMed
29.
Zurück zum Zitat Pascoe L, Frayling TM, Weedon MN et al (2008) Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. Diabetologia 51:1989–1992CrossRefPubMed Pascoe L, Frayling TM, Weedon MN et al (2008) Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles. Diabetologia 51:1989–1992CrossRefPubMed
Metadaten
Titel
Beta cell (dys)function in non-diabetic offspring of diabetic patients
verfasst von
M. Stadler
G. Pacini
J. Petrie
A. Luger
C. Anderwald
on behalf of the RISC Investigators
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 11/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1520-7

Weitere Artikel der Ausgabe 11/2009

Diabetologia 11/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.